tradingkey.logo
tradingkey.logo
Search

Immunovant Inc

IMVT
Add to Watchlist
38.620USD
-0.860-2.18%
Close 07-31 16:00ETQuotes delayed by 15 min
7.97BMarket Cap
LossP/E TTM

Shareholding Stats

Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Roivant Sciences Ltd.
55.68%
Fidelity Management & Research Company LLC
8.34%
Deep Track Capital LP
5.66%
Armistice Capital LLC
2.82%
Baker Bros. Advisors LP
2.68%
Other
24.82%
Shareholders
Shareholders
Proportion
Roivant Sciences Ltd.
55.68%
Fidelity Management & Research Company LLC
8.34%
Deep Track Capital LP
5.66%
Armistice Capital LLC
2.82%
Baker Bros. Advisors LP
2.68%
Other
24.82%
Shareholder Types
Shareholders
Proportion
Corporation
55.68%
Investment Advisor
23.66%
Hedge Fund
18.07%
Investment Advisor/Hedge Fund
10.41%
Individual Investor
1.87%
Research Firm
1.53%
Private Equity
0.98%
Venture Capital
0.69%
Bank and Trust
0.14%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
478
112.99M
55.51%
-342.52K
2025Q4
489
99.16M
48.72%
-16.29M
2025Q3
487
96.71M
55.48%
-16.70M
2025Q2
493
194.27M
113.56%
-2.08M
2025Q1
505
194.81M
114.45%
+16.42M
2024Q4
482
163.29M
104.53%
-8.19M
2024Q3
464
162.18M
111.33%
-1.06M
2024Q2
453
157.67M
108.50%
+1.66M
2024Q1
433
151.47M
104.51%
-605.85K
2023Q4
420
150.13M
103.75%
+991.03K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Roivant Sciences Ltd.
113.32M
55.68%
+16.67M
+17.24%
Dec 12, 2025
Fidelity Management & Research Company LLC
16.97M
8.34%
+2.24M
+15.21%
Dec 31, 2025
Deep Track Capital LP
11.53M
5.66%
+1.80M
+18.48%
Dec 31, 2025
Armistice Capital LLC
5.75M
2.82%
-88.84K
-1.52%
Dec 31, 2025
Baker Bros. Advisors LP
5.46M
2.68%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
5.29M
2.6%
+299.73K
+6.00%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
5.06M
2.49%
-104.30K
-2.02%
Dec 31, 2025
State Street Investment Management (US)
3.79M
1.86%
+894.31K
+30.92%
Dec 31, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Virtus LifeSci Biotech Clinical Trials ETF
1.05%
State Street SPDR S&P Biotech ETF
0.61%
ProShares Ultra Nasdaq Biotechnology
0.51%
Invesco Nasdaq Biotechnology ETF
0.42%
Direxion Daily S&P Biotech Bull 3X Shares
0.38%
iShares Biotechnology ETF
0.15%
Pacer WealthShield ETF
0.1%
JPMorgan BetaBuilders US Small Cap Equity ETF
0.1%
iShares Russell 2000 Growth ETF
0.1%
BNY Mellon US Small Cap Core Equity ETF
0.08%
View more
Virtus LifeSci Biotech Clinical Trials ETF
Proportion1.05%
State Street SPDR S&P Biotech ETF
Proportion0.61%
ProShares Ultra Nasdaq Biotechnology
Proportion0.51%
Invesco Nasdaq Biotechnology ETF
Proportion0.42%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion0.38%
iShares Biotechnology ETF
Proportion0.15%
Pacer WealthShield ETF
Proportion0.1%
JPMorgan BetaBuilders US Small Cap Equity ETF
Proportion0.1%
iShares Russell 2000 Growth ETF
Proportion0.1%
BNY Mellon US Small Cap Core Equity ETF
Proportion0.08%
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.